Bloom Science

Hormones in the brain concept
#ALS #Bloom Science #Clinical trial #Phase I trial #Rare disease

Early trial success for Dravet syndrome and ALS therapeutic

Bloom Science has announced positive topline data from a Phase I clinical trial of BL-001, a potential first-in-class therapeutic the company is developing for Dravet syndrome and amyotrophic lateral sclerosis (ALS). In the trial, BL-001 demonstrated a favourable safety profile and was well… Read More

#News

MRI of the brain
#Biotherapeutics #Bloom Science #epilepsy #Phase I trial

Live biotherapeutic could treat rare paediatric epilepsy

Bloom Science has completed enrolment of healthy adult participants as part of its Phase I clinical trial into BL-001 for Dravet syndrome, a rare paediatric epilepsy. BL-001 is an orally administered Live Biotherapeutic Product reverse translated from the positive clinical outcomes associated with the Ketogenic Diet… Read More

#News